logo
Sign in

FEMASYS INC

SUWANEE, GA · Medtech · Public

Minimally invasive medical devices for women's reproductive and gynecological health

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · femasys.com

Sector
Medtech
Headquarters
SUWANEE, GA
Latest Form D
$30M, Aug 2026
Total capital
$105M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$105M
15 Form D · last Aug 2026
2 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
27
13 pending · first 2021
Rank in peer group#41 of 1112

Capital timeline

20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $105M10th Form D$36.6M12th Form D$6.8M
20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $105M10th Form D$36.6M

Latest events

  • Private capital raisedForm D · SEC · 15th filing$30M
  • Private capital raisedForm D · SEC · 14th filing$8M
  • Private capital raisedForm D · SEC · 13th filing$1.4M
  • Private capital raisedForm D · SEC · 12th filing$6.8M
  • Private capital raisedForm D · SEC · 11th filing$4M
  • Private capital raisedForm D · SEC · 10th filing$36.6M
  • Private capital raisedForm D · SEC · 9th filing$3.3M
  • Private capital raisedForm D · SEC · 8th filing$8M
  • Private capital raisedForm D · SEC · 7th filing$180K
  • Private capital raisedForm D · SEC · 6th filing$30K
  • Private capital raisedForm D · SEC · 5th filing$1M
  • Private capital raisedForm D · SEC · 4th filing$1.8M
  • Private capital raisedForm D · SEC · 3rd filing$642K
  • Private capital raisedForm D · SEC · 2nd filing$1M
  • Private capital raisedForm D · SEC · 1st filing$2.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#41 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Kathy Lee-SepsickResearcherExecutive Officer, DirectorLinked by 8 patents
  • Alistair MilnesDirectorNamed in SEC Form D filings
  • Charles LarsenDirectorNamed in SEC Form D filings
  • Daniel S. CurrieExecutive OfficerNamed in SEC Form D filings
  • Dov ElefantExecutive OfficerNamed in SEC Form D filings
  • Edward UzialkoDirectorNamed in SEC Form D filings
Show all 21 people
  • Edward R. Uzialko, Jr.DirectorNamed in SEC Form D filings
  • Fred AslanDirectorNamed in SEC Form D filings
  • Gary ThompsonExecutive OfficerNamed in SEC Form D filings
  • James E. DorseyDirectorNamed in SEC Form D filings
  • Jeffrey MarcusExecutive Officer, DirectorNamed in SEC Form D filings
  • John Q. AdamsDirectorNamed in SEC Form D filings
  • John DyettDirectorNamed in SEC Form D filings
  • Joshua SilvermanDirectorNamed in SEC Form D filings
  • Lisa E. PeacockExecutive OfficerNamed in SEC Form D filings
  • Marc FinchExecutive OfficerNamed in SEC Form D filings
  • Marcus E. FinchExecutive OfficerNamed in SEC Form D filings
  • Max AzevedoExecutive OfficerNamed in SEC Form D filings
  • Parker H. PetitDirectorNamed in SEC Form D filings
  • Roberta McCawDirectorNamed in SEC Form D filings
  • William WitteDirectorNamed in SEC Form D filings

What it has protected

USPTO · 27 granted of 40
Show all 40 patent records

Related companies, and why

  • Covera Health, Inc.Similar federal contract value in Medtech · null in contracts
  • VERIFAX CORPORATIONSimilar federal contract value in Medtech · null in contracts
  • Scanwell Health, Inc.Similar federal contract value in Medtech · null in contracts
  • GametoSimilar federal contract value in Medtech · null in contracts
  • ATTOGENE CORPORATIONSimilar federal contract value in Medtech · null in contracts
  • TMRW Life Sciences, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .